Neoadjuvant Therapy Module

Speakers


Stephen Broderick, MD, MPHS
Assistant Professor of Surgery
Johns Hopkins Medical Institutions
Baltimore, Maryland

Disclosures


Stephen Broderick, MD, MPHS: No financial relationships to disclose

Learning Objectives

  • Provide a better understanding of genetic mutations and what to look for on report
  • Explain what PDL 1% is and how to answer question if it is a range
  • Discuss what neoadjuvant therapies constitute a platinum doublet
Activity summary
Activity opens: 
09/11/2024
Activity expires: 
09/15/2025
Cost:
$0.00
Part of: 
2024 Advances in Quality & Outcomes: GTSD
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.

Select Take Activity to begin viewing the recording from this session.